{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T20:14:17Z","timestamp":1775765657439,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T00:00:00Z","timestamp":1466640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.adro.2016.06.003","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T09:11:12Z","timestamp":1468660272000},"page":"252-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial"],"prefix":"10.1016","volume":"1","author":[{"given":"Susanne M.","family":"Arnold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh","family":"Kudrimoti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily V.","family":"Dressler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"John F.","family":"Gleason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie L.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William F.","family":"Regine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2016.06.003_bib1","unstructured":"American Cancer Society. Cancer facts & figures\u00a02015. Available at: http:\/\/www.cancer.org\/research\/cancerfactsstatistics\/cancerfactsfigures2015\/index. Accessed July 12,\u00a02016."},{"key":"10.1016\/j.adro.2016.06.003_bib2","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1200\/JCO.2005.04.6136","article-title":"High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma","volume":"24","author":"Licitra","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00001622-200105000-00009","article-title":"Human papillomavirus-associated head and neck squamous cell carcinoma: Mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers","volume":"13","author":"Gillison","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G","article-title":"Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survival","volume":"89","author":"Mellin","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.adro.2016.06.003_bib5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9","article-title":"Human papillomavirus positive squamous cell carcinoma of the oropharynx: A radiosensitive subgroup of head and neck carcinoma","volume":"92","author":"Lindel","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2016.06.003_bib6","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1200\/JCO.2013.54.5228","article-title":"p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma","volume":"32","author":"Chung","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib7","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/annonc\/mdr544","article-title":"Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: An Italian validation study","volume":"23","author":"Granata","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib8","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/sim.3544","article-title":"Bayesian decision sequential analysis with survival endpoint in phase II clinical trials","volume":"28","author":"Zhao","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.adro.2016.06.003_bib9","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1200\/JCO.2015.63.6761","article-title":"Overview of advances in head and neck cancer","volume":"33","author":"Rischin","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib10","first-page":"6247","article-title":"Induction chemotherapy and sequential concomitant chemo-radiation in locally advanced head and neck cancers: How induction-phase intensity and treatment breaks may impact on clinical outcomes","volume":"35","author":"Franco","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.adro.2016.06.003_bib11","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1200\/JCO.2015.61.2929","article-title":"Oral cavity carcinoma: Current management, controversies, and future directions","volume":"33","author":"Chinn","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1053\/j.seminoncol.2004.09.007","article-title":"Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: Evolution of the sequential treatment approach","volume":"31","author":"Posner","year":"2004","journal-title":"Semin Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib13","doi-asserted-by":"crossref","first-page":"8636","DOI":"10.1200\/JCO.2004.00.1990","article-title":"Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer","volume":"23","author":"Hitt","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib14","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/annonc\/mdf172","article-title":"End points for new agents in induction chemotherapy for locally advanced head and neck cancers","volume":"13","author":"Monnerat","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib15","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.1991.9.8.1376","article-title":"Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: Results from a single institution","volume":"9","author":"Vokes","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1200\/JCO.2003.06.006","article-title":"Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil and hydroxyurea chemoradiotherapy: Curative and organ-preserving therapy for advanced head and neck cancer","volume":"21","author":"Vokes","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1200\/JCO.2005.04.017","article-title":"Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: A Southwest Oncology Group Trial","volume":"23","author":"Urba","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib18","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","article-title":"Induction chemotherapy and radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2016.06.003_bib19","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/88.13.890","article-title":"Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group","volume":"88","author":"LeFebreve","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.adro.2016.06.003_bib20","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1200\/JCO.1995.13.4.876","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease","volume":"13","author":"Vokes","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1200\/JCO.2003.06.146","article-title":"Primary chemotherapy in resectable oral cavity squamous cell carcinoma: A randomized controlled trial","volume":"21","author":"Licitra","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib22","unstructured":"Posner MR, Herchock D, Le Lann L, Devlin PM, Haddad RI. TAX 324: a phase III trial of TPF vs PF induction chemotherapy followed by chemoradiotherapy in locally advanced SCCHN: preliminary results of GORTEC 2000-1. Proceedings from the 42nd Annual Meeting of the American Society of Clinical Oncology; June 2-6, 2006; Atlanta, Georgia. Special session."},{"key":"10.1016\/j.adro.2016.06.003_bib23","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1200\/JCO.2002.11.026","article-title":"Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: A University of Pennsylvania Phase II Trial","volume":"20","author":"Machtay","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib24","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/1097-0142(20010301)91:5<940::AID-CNCR1083>3.0.CO;2-A","article-title":"Induction paclitaxel and carboplatin for patients with head and neck carcinoma. Analysis of 62 patients treated between 1994 and 1999","volume":"91","author":"Dunphy","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2016.06.003_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13566-012-0074-3","article-title":"Low-dose fractionated radiation with induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck: 5 year results of a prospective phase II trial","volume":"2","author":"Gleason","year":"2013","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib26","doi-asserted-by":"crossref","first-page":"S502","DOI":"10.1016\/j.ijrobp.2011.06.1026","article-title":"Low-dose fractionated radiation with induction chemotherapy for locally advanced head and neck cancer: 5 year results of a prospective phase II trial","volume":"81","author":"Gleason","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2016.06.003_bib27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0360-3016(00)01471-1","article-title":"Low dose hypersensitivity: Current status and possible mechanisms","volume":"49","author":"Joiner","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2016.06.003_bib28","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/09553000210166606","article-title":"Evidence for the involvement of DNA-dependent protein kinase in the phenomena of low-dose hypersensitivity and increased radioresistance","volume":"78","author":"Marples","year":"2002","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.adro.2016.06.003_bib29","first-page":"1557","article-title":"Low-dose fractionated radiation potentiates the effects of paclitaxel in wild-type and mutant p53 head and neck tumor cell lines","volume":"9","author":"Dey","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.adro.2016.06.003_bib30","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.ijrobp.2003.09.019","article-title":"Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: Results of a new treatment paradigm","volume":"58","author":"Arnold","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2016.06.003_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.adro.2016.06.003_bib32","unstructured":"National Cancer Institute. Common toxicity criteria. http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/ctcaev3.pdf."},{"key":"10.1016\/j.adro.2016.06.003_bib33","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/0003489415579220","article-title":"p16INK4a status and response to induction low-dose fractionated radiation in advanced head and neck cancer","volume":"124","author":"Silver","year":"2015","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.adro.2016.06.003_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.adro.2016.06.003_bib35","unstructured":"Fleiss JL. Statistical Methods for Rates and Proportions.\u00a01981. New York: John Wiley & Sons."},{"key":"10.1016\/j.adro.2016.06.003_bib36","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1200\/JCO.2001.19.14.3333","article-title":"High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck","volume":"19","author":"Regine","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib37","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1158\/1535-7163.MCT-10-0630","article-title":"Low-dose fractionated radiation potentiates the effects of cisplatin independent of the hyper-radiation sensitivity in human lung cancer cells","volume":"10","author":"Gupta","year":"2011","journal-title":"Mole Cancer Therapeutics"},{"key":"10.1016\/j.adro.2016.06.003_bib38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(13)70011-1","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): A randomised phase 3 trial","volume":"14","author":"Haddad","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib39","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.clon.2013.06.010","article-title":"Biomarkers of radiation exposure: Can they predict normal tissue radiosensitivity?","volume":"25","author":"Chua","year":"2013","journal-title":"Clin Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib40","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1200\/JCO.2012.47.7802","article-title":"Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: An individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group","volume":"31","author":"Blanchard","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2016.06.003_bib41","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2016.06.003_bib42","first-page":"5936","article-title":"Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer","volume":"9","author":"Haraf","year":"2003","journal-title":"Clin Cancer Res"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109416300306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109416300306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:35:20Z","timestamp":1762529720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109416300306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S2452109416300306"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2016.06.003","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2016.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 the Authors. Published by Elsevier Inc. on behalf of the American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}